Skip to main content
Equibles
OSCR logo

OSCR · Oscar Health, Inc.

Track OSCR — free

Use OSCR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OSCR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$32.76 +1.98 (+6.43%) At close · Aug 14
Market Cap
$10.11B
Shares
308.64M

Oscar Health, Inc. Earnings Call Transcripts

Every quarterly earnings call for Oscar Health, Inc. (OSCR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲120.4% $978.43M −$192.91M '22 Q3 22-11-08 ▲100.6% $995.13M −$226.05M '22 Q4 23-02-09 ▲51.1% $1.47B −$39.77M '23 Q1 23-05-09 ▲49.6% $1.52B −$15.53M '23 Q2 23-08-08 ▲47.2% $1.44B −$65.40M '23 Q3 23-11-07 ▲43.9% $1.43B −$150.03M '23 Q4 24-02-07 ▲45.8% $2.14B $177.37M '24 Q1 24-05-07 ▲45.9% $2.22B $56.21M '24 Q2 24-08-07 ▲68.3% $2.42B −$54.60M '24 Q3 24-11-07 ▲67.1% $2.39B −$153.55M '24 Q4 25-02-04 ▲42.2% $3.05B $275.27M '25 Q1 25-05-07 ▲29% $2.86B −$228.36M '25 Q2 25-08-06 ▲23.2% $2.99B −$137.45M '25 Q3 25-11-06 ▲17.3% $2.81B −$352.61M '25 Q4 26-02-10 ▲52.6% $4.65B $679.00M '26 Q1 26-05-06 LATEST ▲70.4% $4.88B $361.81M '26 Q2 26-08-06
Capital Markets Day
Investor event
2026-09-16
Oscar Health, Inc. 2026 Investor Day
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call
Confident tone Record profitability and financial performance Product innovation and member navigation Operating leverage and cost discipline
Revenue
$4.88B
▲ 70.4% YoY
Diluted EPS
$1.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Oscar Health, Inc. Q1 FY2026 Earnings Call
Confident tone Risk adjustment and metal mix Individual market dynamics Q1 financial performance
Revenue
$4.65B
▲ 52.6% YoY
Diluted EPS
$2.07
▲ 125% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Oscar Health, Inc. Q4 FY2025 Earnings Call
Confident tone ICRA and defined contribution strategy Membership growth and market share MLR and market morbidity
Revenue
$2.81B*
▲ 17.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Oscar Health, Inc. Q3 FY2025 Earnings Call
Positive tone 2025 Financial Results and 2026 Profitability Outlook Higher Market Morbidity and Risk Adjustment Membership Growth and Geographic Expansion
Revenue
$2.99B
▲ 23.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Oscar Health, Inc. Q2 FY2025 Earnings Call
Balanced tone 2025 financial results and guidance ICHRA growth strategy and acquisitions Market morbidity shift
Revenue
$2.86B
▲ 29% YoY
Diluted EPS
$-0.89
▼ 545% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Oscar Health, Inc. Q1 FY2025 Earnings Call
Confident tone Medical loss ratio and risk adjustment Top-line growth and membership SG&A efficiency
Revenue
$3.05B
▲ 42.2% YoY
Diluted EPS
$0.92
▲ 48.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-04
Oscar Health, Inc. Q4 FY2024 Earnings Call
Confident tone Medical loss ratio and pricing discipline Record financial performance and profitability milestones Above-market growth in individual ACA market
Revenue
$2.39B*
▲ 67.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Oscar Health, Inc. Q3 FY2024 Earnings Call
Confident tone Medical Loss Ratio (MLR) and utilization 2025 open enrollment / ACA market growth SG&A leverage and operating efficiency
Revenue
$2.42B
▲ 68.3% YoY
Diluted EPS
$-0.22
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Oscar Health, Inc. Q2 FY2024 Earnings Call
Confident tone Medical loss ratio / medical costs 2025 and rate filings ACA / enhanced subsidies
Revenue
$2.22B
▲ 45.9% YoY
Diluted EPS
$0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Oscar Health, Inc. Q1 FY2024 Earnings Call
Confident tone Medical Loss Ratio Membership Growth Profitability and Net Income Milestone
Revenue
$2.14B
▲ 45.8% YoY
Diluted EPS
$0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-07
Oscar Health, Inc. Q4 FY2023 Earnings Call
Confident tone Open enrollment and membership growth Medical loss ratio improvement Member experience and NPS
Revenue
$1.43B*
▲ 43.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Oscar Health, Inc. Q3 FY2023 Earnings Call
Revenue
$1.44B
▲ 47.2% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Oscar Health, Inc. Q2 FY2023 Earnings Call
Revenue
$1.52B
▲ 49.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Oscar Health, Inc. Q1 FY2023 Earnings Call
Revenue
$1.47B
▲ 51.1% YoY
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Oscar Health, Inc. Q4 FY2022 Earnings Call
Revenue
$995.13M*
▲ 100.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Oscar Health, Inc. Q3 FY2022 Earnings Call
Revenue
$978.43M
▲ 120.4% YoY
Diluted EPS
$-0.91
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Oscar Health, Inc. Q2 FY2022 Earnings Call
Revenue
$1.02B
▲ 92.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Oscar Health, Inc. Q1 FY2022 Earnings Call
Revenue
$972.76M
▲ 163.3% YoY
Diluted EPS
$-0.36
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Oscar Health, Inc. Q4 FY2021 Earnings Call
Revenue
$496.07M*
▲ 214.6% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Oscar Health, Inc. Q3 FY2021 Earnings Call
Revenue
$443.98M
▲ 336.6% YoY
Diluted EPS
$-1.02
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Oscar Health, Inc. Q2 FY2021 Earnings Call
Revenue
$529.28M
▲ 358.9% YoY
Diluted EPS
$-0.35
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Oscar Health, Inc. Q1 FY2021 Earnings Call
Revenue
$369.39M
▲ 319.3% YoY
Diluted EPS
$-1.00
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 1568651 CUSIP 687793109 13F (30d) 384 filings 379 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)